MovDisordV3, Main, Exploration, bibRecord, 001A53

Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease

Identifieur interne : 001A53 ( Main/Exploration ); précédent : 001A52; suivant : 001A54

Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease

Auteurs : Michael S. Okun [États-Unis] ; Anthony Lang [Canada] ; Joseph Jankovic [États-Unis]

Source :

Movement Disorders [ 0885-3185 ] ; 2010-05-15.

RBID : ISTEX:F94B7C300C6BE8519E0E67511772AE7C00D019C2

Descripteurs français

Pascal (Inist)
- Glutathion, Homme, Maladie de Parkinson, Pathologie du système nerveux.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Glutathione, Glutathione (adverse effects), Human, Humans, Nervous system diseases, Parkinson Disease (drug therapy), Parkinson disease.
MESH :
- chemical , adverse effects : Glutathione.
- drug therapy : Parkinson Disease.
- Humans.

Url:

https://api.istex.fr/document/F94B7C300C6BE8519E0E67511772AE7C00D019C2/fulltext/pdf

DOI: 10.1002/mds.23021

Affiliations:

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease</title>
<author><name sortKey="Okun, Michael S" sort="Okun, Michael S" uniqKey="Okun M" first="Michael S." last="Okun">Michael S. Okun</name>
</author>
<author><name sortKey="Lang, Anthony" sort="Lang, Anthony" uniqKey="Lang A" first="Anthony" last="Lang">Anthony Lang</name>
</author>
<author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<affiliation><country>États-Unis</country>
<placeName><settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F94B7C300C6BE8519E0E67511772AE7C00D019C2</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1002/mds.23021</idno>
<idno type="url">https://api.istex.fr/document/F94B7C300C6BE8519E0E67511772AE7C00D019C2/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002276</idno>
<idno type="wicri:Area/Istex/Curation">002276</idno>
<idno type="wicri:Area/Istex/Checkpoint">000732</idno>
<idno type="wicri:doubleKey">0885-3185:2010:Okun M:reply:based:on</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:20461816</idno>
<idno type="wicri:Area/PubMed/Corpus">001822</idno>
<idno type="wicri:Area/PubMed/Curation">001822</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001653</idno>
<idno type="wicri:Area/Ncbi/Merge">002B80</idno>
<idno type="wicri:Area/Ncbi/Curation">002B80</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002B80</idno>
<idno type="wicri:Area/Main/Merge">001E89</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:10-0288362</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000B02</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002217</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000864</idno>
<idno type="wicri:doubleKey">0885-3185:2010:Okun M:reply:based:on</idno>
<idno type="wicri:Area/Main/Merge">002451</idno>
<idno type="wicri:Area/Main/Curation">001A53</idno>
<idno type="wicri:Area/Main/Exploration">001A53</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease</title>
<author><name sortKey="Okun, Michael S" sort="Okun, Michael S" uniqKey="Okun M" first="Michael S." last="Okun">Michael S. Okun</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, McKnight Brain Institute, University of Florida, Gainesville, Florida</wicri:regionArea>
<placeName><region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lang, Anthony" sort="Lang, Anthony" uniqKey="Lang A" first="Anthony" last="Lang">Anthony Lang</name>
<affiliation wicri:level="1"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Toronto Western Hospital, Movement Disorders Center, University of Toronto and University Health Network, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
<placeName><settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2010-05-15">2010-05-15</date>
<biblScope unit="vol">25</biblScope>
<biblScope unit="issue">7</biblScope>
<biblScope unit="page" from="961">961</biblScope>
<biblScope unit="page" to="962">962</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">F94B7C300C6BE8519E0E67511772AE7C00D019C2</idno>
<idno type="DOI">10.1002/mds.23021</idno>
<idno type="ArticleID">MDS23021</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Glutathione</term>
<term>Glutathione (adverse effects)</term>
<term>Human</term>
<term>Humans</term>
<term>Nervous system diseases</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson disease</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Glutathione</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Glutathion</term>
<term>Homme</term>
<term>Maladie de Parkinson</term>
<term>Pathologie du   système nerveux</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Canada</li>
<li>États-Unis</li>
</country>
<region><li>Floride</li>
<li>Texas</li>
</region>
<settlement><li>Houston</li>
</settlement>
<orgName><li>Baylor College of Medicine</li>
</orgName>
</list>
<tree><country name="États-Unis"><region name="Floride"><name sortKey="Okun, Michael S" sort="Okun, Michael S" uniqKey="Okun M" first="Michael S." last="Okun">Michael S. Okun</name>
</region>
<name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
</country>
<country name="Canada"><noRegion><name sortKey="Lang, Anthony" sort="Lang, Anthony" uniqKey="Lang A" first="Anthony" last="Lang">Anthony Lang</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A53 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001A53 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:F94B7C300C6BE8519E0E67511772AE7C00D019C2
   |texte=   Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease

Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.